Australia's most trusted
source of pharma news
Wednesday, 11 February 2026
Wednesday, 11 February 2026
Subscribe
Login
News Headlines
News Headlines
News
Why CSL's CEO simply had to go
Posted 11 February 2026 AM
The abrupt exit of CSL CEO Dr Paul McKenzie after less than three years in the job was delivered with a scathing explanation from the Board which said he simply "didn't have the skills they wanted for the future".
The announcement that McKenzie would retire, effective immediately, came late yesterday minutes before the end of trading with the company deciding it was best not to ambush investors when the newly appointed interim CEO and Managing Director, Gordon Naylor, appears on the earnings call today.
To see the whole article, please login
Posted 11 February 2026 AM
The abrupt exit of CSL CEO Dr Paul McKenzie after less than three years in the job was delivered with a scathing explanation from the Board which said he simply "didn't have the skills they wanted for the future".
The announcement that McKenzie would retire, effective immediately, came late yesterday minutes before the end of trading with the company deciding it was best not to ambush investors when the newly appointed interim CEO and Managing Director, Gordon Naylor, appears on the earnings call today.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (3)
- Marketing Manager - Sydney
- Senior Brand Manager - Sydney
- Business Analyst / Product Owner – Digital Health (EMR) - Melbourne
Sales & Customer Relations (14)
- Junior Accountant - Sydney
- Territory Manager - Melbourne
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Customer Service Representative - St Leonards
- Hospital Sales Representative - Melbourne
- Customer Service Representative - Pemulwuy
- Senior Territory Sales Manager - Melbourne
- Sales & Key Account Associate - Melbourne
- Inside Sales Specialist - Melbourne
- Key Account Manager - CNS - Sydney
- Pharmaceutical Sales Representative - Gold Coast
- GP Sales Representative - Brisbane
- Clinical Research, Business Development Manager - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Access & Reimbursement (1)
Clinical & Medical, R&D (8)
- Quality & Medical Operations Specialist - Sydney
- Medical Advisor - Sydney
- Head of Medical - Sydney
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Clinical Research, Business Development Manager - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Senior Quality Associate - New South Wales
- Quality & Medical Operations Specialist - Sydney
- Senior Quality Assurance Associate - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Regulatory Specialist - Melbourne
- Senior Technical & Regulatory Associate - Sydney
Other (19)
- Warehouse Assistant - Blacktown
- Pharmacy Assistant - Toongabbie
- QC Analyst -Biochemistry - Melbourne
- SAP Project Lead - Brisbane
- Logistics Manager - Sydney
- Senior Recruitment Consultant - Victoria
- Finance Manager - Melbourne
- Recruitment Consultant - Sydney
- Distribution and Warehouse Technician - Broadmeadows
- Warehouse Associate - Chatswood
- Logistics Specialist - Macquarie Park
- Chief Operating Officer - Sydney
- Chief Operating Officer - Sydney
- Dedicated Principal Agent - Pemulwuy
- GP Rep Bundaberg Contract - Bundaberg
- Warehouse & Logistics Officer - Macquarie Park
- Commercial Lead - Melbourne
- Commercial Lead - Melbourne
- Senior Payroll Officer - 41808-1 - Melbourne
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.